Salahaldin A. Tahir and colleagues additionally discovered a significant 1.34-fold increase in autoantibodies against CD74 in patients with immune-related pneumonia after receiving immune checkpoint inhibitor therapy, suggesting a role for CD74 autoantibodies in pneumonia (34). Here, CD74 is linked to susceptibility to pneumonia measurement.